Status | Study |
Withdrawn |
Study Name: Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol Condition: Metrorrhagia Date: 2012-03-08 Interventions: Drug: barrier methods |
Completed |
Study Name: Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial MMPs Condition: Breakthrough Bleeding Date: 2011-11-08 Interventions: Drug: Doxycycline 40 mg orally at the start of cycle 3 (study day 57) for 28 days. |
Terminated |
Study Name: Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist Condition: Dysfunctional Uterine Bleeding Date: 2011-06-14 Interventions: Drug: Medroxyprogesterone 17-Acetate MPA pills 20 mg (2 X 10 mg) twice daily for 3 weeks |
Completed |
Study Name: Endometrial Ablation With Non-hysteroscopic Methods Condition: Dysfunctional Uterine Bleeding Date: 2010-08-02 Interventions: Device: MEA Microwave endometr |
Completed |
Study Name: DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding Condition: Dysfunctional Uterine Bleeding Date: 2010-06-21 Interventions: Drug: Medroxyprogesterone 17-Acetate |
Completed |
Study Name: Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation Condition: Metrorrhagia Date: 2007-11-21 Interventions: Drug: Femring® |
Completed |
Study Name: CavatermTM vs TCRE in Women With DUB Condition: Dysfunctional Uterine Bleeding Date: 2007-10-24 Interventions: Device: Thermal Balloon Endometrial Ablation |
Completed |
Study Name: Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing® Condition: Breakthrough Bleeding Breakthrough Spotti Date: 2007-05-16 Interventions: Other: remove ring if bleeding or spotting occurs more than 5 days |
Completed |
Study Name: A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale Condition: Breakthrough Bleeding Date: 2006-10-30 Interventions: Drug: DR-1031 Active therapy c |
Completed |
Study Name: An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen Condition: Metrorrhagia Date: 2006-06-23 Interventions: Drug: Norgestimate/Ethinyl Estradiol tablet |